Phase II trial investigating the tolerability and efficacy of ralfinamide in patients with third molar, post-extraction dental pain

Trial Profile

Phase II trial investigating the tolerability and efficacy of ralfinamide in patients with third molar, post-extraction dental pain

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Mar 2008

At a glance

  • Drugs Ralfinamide (Primary)
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Mar 2008 Results will be reported at AAN 2008.
    • 19 Feb 2008 Status changed from recruiting to in progress, in accordance with media release 9085420.
    • 09 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top